AIMCA
LXRX icon

Alberta Investment Management Corp (AIMCo)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,600
Closed -$195K – 761
2016
Q2 		$195K Buy
+13,600
New +$184K ﹤0.01% 650

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s LXRX Position: Q3 2016 in Review

Alberta Investment Management Corp (AIMCo) sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2016, closing a stake of 13,600 shares — an estimated $195K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in LXRX in Q2 2016 and held it in 1 quarter. The position peaked at $195K in Q2 2016. 142 funds tracked by Wall St. Rank hold LXRX as of Q3 2016.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Lexicon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 13,600 Lexicon Pharmaceuticals shares in Q3 2016, an estimated $195K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Lexicon Pharmaceuticals position peaked at $195K in Q2 2016.
  • 142 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2016.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2016, filed 2 Nov 2016.